pISSN 1226-6051
eISSN 2508-786X

Table. 1.

Table. 1.

Chemotherapy regimen including bevacizumab used for colorectal cancer

Regimen Dose and schedule
Capecitabine-Bevacizumab D1: Bevacizumab 5 mg/kgD1~14 Capecitabine 2,500 mg/m2
FL*-Bevacizumab D1: Bevacizumab 5 mg/kg, 5-FU§ 400 mg/m2 D1, 2: 5-FU§ 1,200 mg/m2/day every 2 weeks
FOLFIRI-Bevacizumab D1: Bevacizumab 5 mg/kg Irinotecan 180 mg/m2, Leucovorin 200 mg/m2, 5-FU§ 400 mg/m2 D1,2: 5-FU§ 1,200 mg/m2/day every 2 weeks
FOLFOX-Bevacizumab D1: Bevacizumab 5 mg/kg Oxaliplatin 85 mg/m2, Leucovorin 200 mg/m2, 5-FU§ 400 mg/m2 D1,2: 5-FU§ 1,200 mg/m2/day every 2 weeks

FL*: 5-Fluorouracil, leucovorin, FOLFIRI: 5-Fluorouracil, leucovorin, irinotecan, FOLFOX: 5-Fluorouracil, leucovorin, oxaliplatin, 5-FU§: 5-fluorouracil

Korean J Clin Pharm 2020;30:234-42 https://doi.org/10.24304/kjcp.2020.30.4.234
© 2020 Korean J Clin Pharm